Intelligence Profile
Clinical Applications
Female hormone replacement therapy (HRT) is used across several clinical contexts, though the available evidence from recent studies is limited to specific populations and conditions.
Primary Indications
Reproductive Medicine and Fertility Treatments
HRT plays a key role in assisted reproductive technology, particularly in frozen embryo transfer (FET) cycles. Recent research has examined optimization of hormone protocols, including the use of low-dose estradiol to improve clinical pregnancy rates and the monitoring of serum progesterone levels for "rescue" protocols in hormone replacement FET cycles. One study analyzed 917 FET cycles to evaluate progesterone rescue strategies, though specific outcomes are not detailed in the available evidence.
Premature Ovarian Insufficiency and Hypogonadism
HRT is used in women with hypogonadotropic hypogonadism, with recent research examining long-term oncological implications through propensity-matched studies. The therapy is also utilized in childhood cancer survivors who develop premature ovarian insufficiency, a population that shows low bone mineral density at long-term follow-up.
Turner Syndrome
A pilot study compared transdermal versus oral hormone replacement therapy for bone mass density in Turner syndrome patients, indicating HRT's role in managing the endocrine complications of this genetic condition.
Specialized Applications
Post-Transplant Care
HRT is being studied for managing gonado-sexual health in reproductive-age women following hematopoietic transplant, addressing menstrual patterns and hormonal deficits that commonly occur after such procedures.
Surgical Outcomes
Emerging research has investigated the effect of preoperative HRT on surgical outcomes, specifically in postmenopausal women undergoing rotator cuff repair, suggesting potential applications beyond traditional hormonal indications.
Menopausal Symptoms
Current clinical trials are examining HRT for menopausal arthralgia, with studies in Phase 2/3 recruitment stages.
Evidence Limitations
The available evidence is primarily from 2026 publications and focuses on specialized populations rather than the more common menopausal symptom management traditionally associated with HRT. Most studies appear to be observational or small pilot studies, and specific efficacy data, safety profiles, and comparative outcomes are not provided in the available abstracts.
This information is for educational purposes only and should not replace personalized medical advice. Consult with a healthcare provider for individual treatment decisions regarding hormone replacement therapy.